OMEGA HEALTHCARE INVESTORS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OMEGA HEALTHCARE INVESTORS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $949.74M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $878.24M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.06B | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $892.38M | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $246.67M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $233.20M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $225.28M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $223.69M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $590.19M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $406.33M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $242.18M | Feb 9, 2026 |
| FY2014 | Dec 31, 2014 | $56.99M | Feb 27, 2015 |
| FY2014 | Sep 30, 2014 | $61.71M | Feb 27, 2015 |
| FY2014 | Jul 1, 2014 | $46.82M | Feb 27, 2015 |
| FY2014 | Jun 30, 2014 | $46.82M | Feb 27, 2015 |
| FY2014 | Mar 31, 2014 | $55.83M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $47.21M | Feb 27, 2015 |
| FY2014 | Sep 30, 2013 | $38.14M | Feb 27, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $551.75M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $497.59M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $315.17M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $559.95M | Feb 26, 2019 |
| FY2017 | Dec 31, 2015 | $411.27M | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $345.31M | Aug 9, 2017 |
| FY2015 | Dec 31, 2013 | $265.68M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $214.97M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $137.80M | Feb 11, 2014 |
| FY2012 | Dec 31, 2010 | $148.94M | Feb 28, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $878.55M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $749.43M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $617.74M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $625.73M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $722.14M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $708.26M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $553.75M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $499.37M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $577.91M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $624.77M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.05B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $9.90B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $9.12B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $9.41B | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $9.64B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $9.50B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $9.80B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $8.59B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $8.77B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $8.95B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.61B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $5.17B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $5.36B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $5.60B | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $5.53B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.46B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $5.46B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.83B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $4.89B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $4.74B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.18B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $4.54B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $3.57B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $3.61B | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $3.91B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $3.84B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.14B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $3.44B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $3.56B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $3.86B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $644.63M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $643.66M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $643.90M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $643.15M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $651.42M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $651.74M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $644.42M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $643.95M | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $644.69M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $643.47M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.68B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $3.68B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $3.44B | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $3.01B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.59B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.46B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $2.13B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.84B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.74B | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.02M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $518.34M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $442.81M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $297.10M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $20.53M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $163.54M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $24.12M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $10.30M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $85.94M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $93.69M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.26B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $4.84B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $5.07B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $5.29B | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $5.25B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $5.17B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $5.14B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.54B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $4.57B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $4.37B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 295.54M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 279.13M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 245.28M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 234.25M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | 239.06M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | 231.20M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 226.63M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 202.35M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 198.31M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | 196.14M | Feb 26, 2019 |